Patentation of medicinal plants: controversy and discussions

Patentation of medicinal plants: controversy and discussions

patenting of medicinal plants: controversy and discussions

introduction

The patenting of medicinal plants is a topic that repeatedly causes controversial discussions in the scientific and medical community. While some see the patenting of medicinal plants as a possibility of promoting innovations and the protection of intellectual property, others argue that this makes it difficult to access natural resources and traditional knowledge. In this article we will deal with the different points of view and the associated controversy.

background

The use of medicinal plants for the treatment of diseases and the promotion of health is a practice that has existed in many cultures for thousands of years. Numerous drugs that are available on the market today are based on vegetable active ingredients. Examples of this are the use of willow bark for pain relief (from which the aspirin was later developed) or the use of taxus plants for the production of cancer medication.

The search for new active ingredients and medication is an important area of ​​medical research and development. Natural resources such as medicinal plants are often examined in order to find potentially therapeutic active ingredients. The patenting of these discoveries enables companies to protect their investments and have exclusive rights to use and market these active ingredients.

The patenting process

Medicinal plants are patented in a similar way to patenting other inventive activities. The first step is to prove the discovery as new and not obviously. This is achieved by thorough research of the state of the art and other relevant information. If the discovery is considered new and not obvious, a patent application can be submitted.

It is important to note that not all aspects of a medicinal plant can be patented. For example, a certain use of an active ingredient or a specific manufacturing process can be patented, but not the plant itself. This is because plants are regarded as natural resources that cannot be protected by patents.

supporter of patenting

The supporters of patenting medicinal plants argue that this creates incentives for the research and development of new medication and therapies. Through the possibility of maintaining exclusive rights to use the active ingredients discovered, companies can protect their investments and achieve profits. This promotes progress in medicine and enables the patient to access innovative treatment options.

In addition, supporters believe that the patenting of medicinal plants enables intellectual property. Research and development in the field of natural products often requires considerable investments, and the presence of patents ensures that companies can recover these investments and continue to invest in research and development.

criticism and concerns

On the other hand, there are also numerous critics of patenting medicinal plants. One of the main criticisms is that this makes access to natural resources and traditional knowledge difficult. Many medicinal plants have been used by indigenous communities for centuries to treat diseases or to promote health. The patenting of these plants and their active ingredients can cause these practices to be restricted or commercialized.

Another point of criticism is that the patenting of medicinal plants can drive up the prices for medication. If companies have exclusive rights to the use and marketing of active ingredients, they can define the prices at their own discretion without allowing the competition from generic versions. This can make access to vital medication more difficult for many people.

regulatory aspects

The patenting of medicinal plants is subject to various regulatory framework. In some countries, natural products and traditional knowledge cannot be patented. Such patents can be granted in other countries, on the condition that certain criteria are met. These criteria can include the scope of the open information, the proof of considerable progress towards the state of the art and the benefits for society.

International there are efforts to improve the protection of copyright, traditional knowledge and genetic resources. The Nagoya protocol, an important international contract, aims to make access to genetic resources fair and fairly and to strengthen the advantage compensation mechanisms between countries of origin and companies.

conclusion

The patenting of medicinal plants is a topic that shows different opinions and approaches. While some consider patenting as a means of promoting innovations and the protection of intellectual property, others see a threat to access to natural resources and traditional knowledge. The controversial discussion in this area is expected to continue, while international laws and provisions to regulate the patenting of medicinal plants are being developed.

sources:
- (link removed)
- (link removed)
- (link removed)
- (link removed)